NR2C2
Chr 3nuclear receptor subfamily 2 group C member 2
Also known as: TAK1, TR4
This gene encodes an orphan nuclear receptor that functions as a ligand-independent transcription factor, regulating gene expression during early embryonic development, spermatogenesis, and cerebellum development by binding to hormone response elements and modulating various nuclear receptor signaling pathways. Mutations cause autosomal dominant neurodevelopmental disorders with cerebellar involvement and intellectual disability. The gene is highly constrained against loss-of-function variation in the population, indicating that such mutations are likely to be pathogenic.
Population Genetics & Constraint
gnomAD v4 — loss-of-function & missense intolerance
Highly LoF-intolerant (top ~10% of genes)
Highly missense-constrained (top ~0.1%)
The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).
Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.
ClinVar Variant Classifications
0 submitted variants in ClinVar
Protein Context — Lollipop Plot
NR2C2 · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
3D Protein StructureAlphaFold
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
No active trials found for this gene.
Search ClinicalTrials.gov →External Resources
Links to major genomics databases and tools